Replimune Group, Inc. (REPL)

7.01 -0.03 (-0.43%) USD  |  NASDAQ  |  Jan 20, 16:00
6.99 -0.02 (-0.29%) After-Hours: 20:00
More

Replimune Group Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Rapt Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Anavex Life Sciences Corp. Upgrade